Results 121 to 130 of about 1,669,562 (240)
MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
MR-guided radiotherapy (MRgRT) is novel treatment modality in Radiation Oncology that could allow a higher precision and tolerability of Radiation Treatments.
Antonio De Simone BS +13 more
core +1 more source
Summary While marginal zone lymphoma (MZL) is generally indolent, outcomes following relapse remain poorly defined. This study utilized the indolent Non Follicular 10 (NF10) prospective database to characterize survival and identify prognostic drivers in patients failing initial systemic therapy. The study analysed 122 patients with relapsed MZL.
Stefano Luminari +28 more
wiley +1 more source
Characterization of mechanical and radiation isocenter on an MR-guided radiotherapy (MRgRT) Linac. [PDF]
Bassiri N, Bayouth JE, Mittauer KE.
europepmc +1 more source
Primary antiphospholipid syndrome comprises distinct inflammatory subgroups defined by cytokine profiling. A shared pro‐inflammatory signature is present across all patients, whereas arterial thrombosis demonstrates enhanced inflammatory activation compared with venous thrombosis, suggesting divergent pathogenic mechanisms and opportunities for ...
Catherine B. Ducker +6 more
wiley +1 more source
Objective: Magnetic resonance-guided adaptive stereotactic radiotherapy (MRgRT) represents an innovative approach in radiation oncology, combining real-time MR imaging with treatment delivery systems.
Sylwia Szablewska, Krzysztof Roszkowski
doaj +1 more source
Higher chimeric antigen receptor‐T expansion at day 7 is associated with improved progression‐free survival but also increased toxicity in axi‐cel treated patients with R/R large B‐cell lymphoma, independent of other baseline patient and disease characteristics.
Brydon Panozzo +17 more
wiley +1 more source
A phase IIa study of the anti‐PD‐L1 antibody avelumab in relapsed/refractory PTCL: The AVAIL‐T trial
The AVAIL‐T study, the first evaluation of programmed death ligand 1 (PD‐L1) blockade in relapsed/refractory peripheral T‐cell lymphomas (PTCL), demonstrated limited single agent activity with durable responses seen in a minority. Circulating tumour DNA revealed distinct mutational dynamics and mass cytometry identified perturbed T‐cell subsets ...
Matthew J. Ahearne +28 more
wiley +1 more source
This study aimed to develop and publicly release an in-house software package that converts the binary file format of 2D cine magnetic resonance (MR) images acquired through the Treatment Session Manager (TSM) of MOSAIQ on the Elekta Unity (Elekta AB ...
Jiwon Sung +4 more
doaj +1 more source
Symptom‐guided reduction of BCG dwell time: findings from the north‐REG randomized trial
Objectives To evaluate the impact of personalized dwell‐time (DT) reductions on symptom prevalence and systemic toxicities in patients undergoing Bacillus Calmette–Guérin (BCG) instillation for non‐muscle invasive bladder cancer (NMIBC). Methods Within a multinational randomized controlled trial (North‐REG Dwell Time Study [NCT04701151]), 225 patients ...
Lene Munk +15 more
wiley +1 more source

